fMRI predicts benign brain tumors that turn malignant
Perfusion-weighted MRI can anticipate the transformation of low-grade gliomas into malignant tumors up to a year earlier than other imaging tests, according to researchers. The technique could help select patients who may benefit from more aggressive treatment.
Perfusion-weighted MRI can anticipate the transformation of low-grade gliomas into malignant tumors up to a year earlier than other imaging tests, according to researchers. The technique could help select patients who may benefit from more aggressive treatment.
Adam Waldman, Ph.D., and colleagues at the Charing Cross Hospital in London prospectively enrolled 13 patients with low-grade gliomas for two years ending in August 2002. Patients underwent perfusion- and contrast-enhanced MRI every six months for up to three years to check for tumor malignancy. Investigators found that increases in blood volume by perfusion MRI suggested malignancy a year or more before it could be observed by contrast MR. They published their findings in the April issue of Radiology.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
